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Label-Free in Situ Quantiﬁcation of Drug in Living Cells at
Micromolar Levels Using Infrared Spectroscopy
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Institute of Pharmaceutical Science, King's College London, London SE1 9NH, U.K.
*S Supporting Information
ABSTRACT: Quantifying the rate and the amount of drug
entering live cells is an essential part of the medicine
development process. Infrared spectroscopy is a label-free,
chemically selective tool for analyzing the composition of live
cells in culture that has the potential to quantify, in situ, the
amount of drug entering living cells in a nondestructive
manner, although its sensitivity is currently limited. This paper
is the ﬁrst to demonstrate in situ quantiﬁcation of the cancer
drug, ﬂuorouracil, in live cells at a therapeutically relevant concentration using Fourier transform infrared spectroscopy. To
achieve the required improvement in detection and quantitation limits of the IR measurement, two strategies were exploited.
First, a sampling method called multibounce attenuated total reﬂection was used to optimize the signal while second, a long pass
ﬁlter in combination with a mercury cadmium telluride detector was used to reduce the instrument noise. Using these novel
adaptations, it was possible to quantify 20 μM of ﬂuorouracil in cell culture medium using a standard FTIR instrument, while it
was possible to quantify and measure the ﬂux of ﬂuorouracil in situ in living cells treated with an 80 μM drug.
The ability to measure drug concentration in living cells in aselective, nondestructive manner and without recourse to
labeling the drug has the important advantage of eliminating
any unwanted and/or unexpected interference to the drug’s
natural diﬀusive processes. The analytical method should
therefore be able to detect and quantify the drug at therapeutic
concentrations under biological relevant conditions. The
precise concentration to be detected, however, depends upon
the drug under investigation, with a recent study1 of the cancer
drug ﬂuorouracil (5-FU) indicating that plasma concentrations
5, 19, and 31 min after a patient receiving a 370 mg/m2 dose of
5-FU were 110, 60, and 15 μM, respectively.
Fourier transform infrared (FTIR) spectroscopy is a widely
available analytical technique that enables a label-free and
nondestructive analysis of drug molecules. One area where
FTIR spectroscopy is increasingly ﬁnding application is the
measurement of living cells, including single cells2−6 and
populations of cells,7−9 such as the characterization of normal
cells from carcinoma,2 response of cells to mechanical stress,3
chemical stress,4 optical stimulation,5 protein aggregation,10 cell
attachment,11−13 cell death,14,15 cell diﬀerentiation,16 and cell
activation.17,18 One factor that limits the use of FTIR for drug
analysis in living cells is the water band that dominates the IR
spectra and which arises from water being the major
component of living cells. Due to the low concentrations of
drug that are generally present in the body, the presence of the
water band in the IR spectrum limits the quantiﬁcation and
detection limit of the analysis of drug diﬀusion into cells.
However, FTIR spectra of living cells when obtained with high
signal-to-noise ratios (SNR) will, after the subtraction of water
band, reveal the spectral features of components of interest that
are of low concentrations such as the added drug in the living
cells. The intrinsic SNR of a spectrometer can be estimated by
the following equation19
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The equation implies that SNR is proportional to Θ (the
throughput of light), ξ (spectrometer eﬃciency), U (spectral
energy density), Δν (spectral resolution), D (detector
sensitivity), and √t (time or the number of coadditions) and
inversely proportional to √AD (the detector area).19
Although it is possible to increase detector sensitivity (D)
and therefore SNR by employing a highly sensitive liquid-
nitrogen-cooled mercury cadmium telluride (MCT) detector
instead of room temperature detectors such as lithium tantalum
oxide (LiTaO3) or deuterated triglycine sulfate (DTGS)
detectors, MCT detectors are only advantageous in situations
where the throughput of light is low. Highly sensitive MCT
detectors are easily saturated and, consequently, attenuators or
small apertures are often employed to reduce the throughput of
light (Θ) to ensure that saturation of the detector does not
occur, thereby reducing the advantage gained from increasing D
by use of a more sensitive detector.
One way to overcome this problem is the realization that
most of the useful spectral information is contained in the
carbonyl to ﬁngerprint region (namely 1800−500 cm−1) and
that by using a long pass ﬁlter, it is possible to reduce the
Received: August 1, 2014
Accepted: November 6, 2014
Published: November 6, 2014
Article
pubs.acs.org/ac
© 2014 American Chemical Society 11673 dx.doi.org/10.1021/ac503915c | Anal. Chem. 2014, 86, 11673−11679
This is an open access article published under a Creative Commons Attribution (CC-BY)
License, which permits unrestricted use, distribution and reproduction in any medium,
provided the author and source are cited.
D
ow
nl
oa
de
d 
vi
a 
K
IN
G
'S
 C
O
LL
EG
E 
LO
N
D
O
N
 o
n 
A
pr
il 
2,
 2
01
9 
at
 1
4:
10
:4
7 
(U
TC
). 
Se
e 
ht
tp
s:/
/p
ub
s.a
cs
.o
rg
/sh
ar
in
gg
ui
de
lin
es
 fo
r o
pt
io
ns
 o
n 
ho
w
 to
 le
gi
tim
at
el
y 
sh
ar
e 
pu
bl
ish
ed
 a
rti
cl
es
. 
overall intensity of light and hence avoid saturating the MCT
detector without reducing the throughput of light in the
spectral region of interest. Although long pass ﬁlters have been
previously used to increase scan speed in FTIR imaging
experiments,20,21 and the signal-to-noise of spectra in diﬀerence
FTIR spectroscopy of bacteria,22 to our knowledge, they have
not been used to improve the SNR of a FTIR measurement of
drug in solution and in living cells. To optimize the spectral
signal from the living cells and minimize the disturbance from
the culturing medium, the multibounce attenuated total
reﬂection (ATR) measurement mode where only the living
cells adhered to the measuring surface of the ATR element
(Figure 1) is measured. Increasing the path length in the living
cell can signiﬁcantly increase the signal, hence the sensitivity
and the detection limit, when compared to transmission
measurement. However, increasing the path length will also
increase the noise and, therefore, an optimal path length for the
measurement of living cell has been investigated (details can be
found in Figure S-1 of the Supporting Information).
The present work demonstrates the potential of using a long
pass IR ﬁlter in combination with a zinc sulﬁde (ZnS)
multibounce ATR, which produce the optimal path length,
FTIR measurement to acquire spectra of aqueous drug solution
and live cells under treatment of drug with a suﬃciently
improved SNR to enable quantiﬁcation of drug in living cells.
Aqueous solutions of the drug, 5-ﬂuorouracil (5-FU), at
therapeutically relevant concentrations of between 10−700
μM, were used as test samples to demonstrate the level of
detection and quantitation limits that can be achieved using this
relatively simple methodology. Many cell lines were found to
adhere and grow well on the ZnS substrate as demonstrated by
Wehbe et al.23 as well as from our preliminary tests against
HeLa, macrophage, PC-3, and insulin-secreting beta (INS) cell
lines. In this study, the INS cell line was used as the test cells.
Diﬀerence FTIR spectra of drug diﬀusing in living cell were also
determined to demonstrate the low noise levels that can be
achieved using this approach, and HPLC was used as an
orthogonal method to conﬁrm the results obtained.
■ EXPERIMENTAL SECTION
Multibounce ATR FTIR Accessory. A temperature
controlled 20 bounce (10 bounces on the measurement side)
ATR accessory trough plate (HATR, Pike technologies) and a
45° ZnS ATR element (Crystran Ltd., U.K.) was used. The
trough plate has a measurement area of ∼500 mm2, where the
living cells can attach and be measured. The approximate area
occupied by attached insulin-secreting beta cells (INS) is 1.7 ×
10−4 mm2. It is therefore estimated that at 100% conﬂuence, ∼3
million cells can be attached and measured.
Live Cell Preparation. Insulin secreting beta cells (INS cell
line, kindly provided by Dr Andrei Tarasov from University of
Oxford) were maintained in T25 cell culture ﬂasks using RPMI
medium supplemented with 10% FBS and 2 mM L-glutamine,
in a 5% CO2 environment at 37 °C. The cells were trypsinised
and harvested when they had reached ∼80% conﬂuence. The
cells were then centrifuged into a pellet and resuspended in L15
medium supplemented with 10% FBS, 2 mM L-glutamine, 100
U/mL penicillin, and 100 U/mL streptomycin. L15 was used to
allow closed chamber culturing with air as the gaseous phase.
The cell suspension was diluted in 10 mL of medium to reach a
cell density of ∼1.2 × 106 cell per mL and 2.5 mL of the
resulting cell suspension (i.e., ∼3 million of cells) seeded
directly onto the multibounce, temperature-controlled ATR
trough which was then well-sealed and maintained at 35 °C and
covered with a warm blanket to prevent evaporation. After
incubating overnight, the relatively high cell seeding density
ensured a high conﬂuency of cells adhered to the measuring
surface. The cells were incubated for a further 2 h with the
spectrum of the cell monitored at a 4 min interval. Experiments
were conducted when the change in the spectrum of cells was
stabilized and a steady but small increase in the absorbance of
the cells was established.
Drug Solutions Preparation. A 5 and 10 mM stock
solutions of ﬂuorouracil (5-FU, Sigma-Aldrich, U.K.) in L15
media were produced by dissolving the required amount of 5-
FU in the medium and stirring until dissolved. To build the
calibration curves, standard solutions of 5-FU were produced
by diluting the 5 mM stock solution in L15 media to obtain 10,
20, 30, 40, 50, 100, and 190 μM for the system with the MCT
detector and 200, 300, 400, 600, 800, 1000, and 1200 μM for
the system with the LiTaO3 detector.
FTIR Measurement of Samples. Continuous scan FTIR
spectrometers (Frontier, PerkinElmer) were ﬁtted with a
LiTaO3, a DTGS, and a MCT detector and a long pass ﬁlter
(IR LWP ﬁlter at 5.5 μm, Infrared Filter Solution Ltd.) to allow
selection of the IR bands with wavenumber below 1850 cm−1
passing to the sample chamber. The cells on the ATR element
were exposed to 80 or 400 μM of drug by adding 20 or 105 μL
of the 10 mM stock solution of 5-FU to the cell culture on the
trough plate, which has a volume of medium of 2.5 mL. The
cells exposed to 80 μM of 5-FU were measured using the MCT
detector with the long pass ﬁlter, while the cells exposed to 400
μM of 5-FU were measured using the LiTaO3 detector, both
with a scanning time of 4 min. The standard solutions for the
calibration curves were measured using the MCT detector with
the long pass ﬁlter, the DTGS detector, and the LiTaO3
detector with a scanning time of 4 min. Deionized water was
measured using the LiTaO3 and the DTGS detector without
attenuation of light, the MCT detector with attenuation of light
by the means of a small aperture, and the MCT detector with
attenuation of light by the means of the long pass ﬁlter and with
a scanning time of 1 min. All measurements were acquired with
a spectral resolution of 8 cm−1 and a spectral range of 4000−
900 cm−1 or 1850−900 cm−1 (when the long pass ﬁlter is
used). The strong Norton-Beer apodization function and self-
phase correction was chosen for the process of the interfero-
Figure 1. Schematic of a multibounce ATR FTIR measurement setup.
The IR beam interacts with the sample with a depth of penetration of
typically a few micrometers, which is deep enough to measure
absorbance from the bulk of the adherent cells but shallow enough to
avoid absorbance from the culture medium. The signal from the cell
can therefore be increased by using the multibounce ATR method
without unwanted attenuation of light from the culture medium. The
size and thickness of the multibounce ATR element can be chosen to
achieve the optimal path length. The signal from the analyte is
proportional to the number of bounces (and hence the total path
length) used in the ATR measurement.
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gram. Spectrum 10 (PerkinElmer) was used for all data
processing.
HPLC Measurement of Intracellular 5-FU Concen-
tration. INS cells were seeded in 12 well plates, in similar
conditions to the ones used for the ATR-FTIR experiments,
using the same medium and cell density (∼1 million cells/
well). The cells were incubated at 37 °C until settling and
reaching conﬂuence. 5-FU was added at a concentration of 80
μM. At times 0, 4, 8, 16, and 24 min after the addition of 5-FU,
the cells were washed three times with PBS, resuspended in 500
μL of 50% MeOH/H2O, sonicated 5 × 10 s, centrifuged 10 min
at 5000g, and the supernatant was analyzed by HPLC.
The HPLC−UV/vis analysis of 5-FU was carried out in a
Jasco 2000Plus HPLC system equipped with a Column Oven
CO-2067Plus and UV/vis Detector UV-2075Plus. A column
Phenomenex Gemini-NX 5 μm C18 110A was used. Twenty
ﬁve microliters of sample was injected, and an elution gradient
consisting of methanol and water24 was used as following: 0
min, 2% methanol; 8 min, 10% methanol; 15 min, 80%
methanol; 17 min, 80% methanol, with a ﬂow of 1.000 mL/
min. The detection was carried out at 260 nm. A 5-FU
calibration curve built by injecting standard solutions at the
concentrations of 0, 0.5, 2, 10, 20, and 100 μM in the same
conditions. The intracellular volume was calculated after
determination of the cell pellet volume, after centrifugation
for 10 min at 600g, in triplicate from the same batch of cells.25
■ RESULTS AND DISCUSSION
Deionized water was ﬁrst used as test solution to demonstrate
the reduced noise level achievable with the long pass ﬁlter. The
result (see Figure S-2 of the Supporting Information) shows
that the measurement using the DTGS detector and the MCT
detector without the long pass ﬁlter exhibited similar peak-to-
peak noise levels of ∼0.018% or a SNR of ∼5500 while the
LiTaO3 has a higher noise level of ∼0.05% or a SNR of ∼2000.
The reason why the SNR was not signiﬁcantly improved when
using the MCT detector despite the sensitivity, D, is an order of
magnitude higher than the DTGS or the LiTaO3 detector is
because the light source was attenuated by means of an
aperture to avoid the saturation of the MCT detector.
However, when the light was attenuated by a long pass ﬁlter
that cut oﬀ IR light with wavenumber above 1850 cm−1 instead
of a small aperture, it is clear that the measurement can be
performed without the attenuation of light in the 1500−1000
cm−1 region. Signiﬁcantly, the noise level is greatly improved
with the peak-to-peak noise level in the 1500−1000 cm−1
region of ∼0.003% or a SNR of 33000 (see Figure S-2 of the
Supporting Information), which is a 6-fold improvement
compared to the DTGS detector and more than 15-fold
improvement compared to the LiTaO3 detector without an
increase in scan time or reduction of spectral resolution.
The limits of detection in cell culture medium using the
LiTaO3, the DTGS, and the MCT detector coupled with the
long pass ﬁlter have been compared using 5-FU as the test drug.
5-FU was selected because it is a widely used, and therefore
relevant, drug molecule. Furthermore, the drug is studied at an
in vitro concentration of 10 μM−1 mM,26 which should be
detectable using the methodology in the present study. 5-FU
has a number of major spectral bands in the IR ν(CO) and
ﬁngerprint region, including a relatively broad band at 1690
Figure 2. Diﬀerence IR spectra of 5-FU in medium at various concentration levels measured with (A) a LiTaO3 detector and (B) a MCT detector
with a long pass ﬁlter. (C and D) Calibration curves obtained from the measurement of a set of standard samples of known 5-FU drug
concentrations. (C) Measurement with a LiTaO3 detector. (D) Measurement with a MCT detector with a long pass ﬁlter. The integrated
absorbance is calculated based on the band at 1254 cm−1 with a straight baseline between the points, 1264 and 1243 cm−1. The vertical error bars
represent the contribution from spectral noise, and the horizontal error bars represent the uncertainties arising from the dilution of the drug solution.
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cm−1 and a sharp band at 1254 cm−1 (see Figure S-3 of the
Supporting Information). The band at 1690 cm−1 is slightly
stronger than the 1254 cm−1 band, but it overlaps with the
stronger water band at 1640 cm−1 and therefore is not a
suitable marker for the current analysis. The band at 1254 cm−1
is in a region where water has relatively low absorbance and
therefore absorbance of this band was used to construct the
calibration curve. The diﬀerence IR spectra of drug in medium
showing the 5-FU band at 1254 cm−1 as determined using the
LiTaO3 and MCT detectors are shown in Figure 2 (panels A
and B). Results from the DTGS detector are shown in Figure S-
4 of the Supporting Information. Figure 2A shows that the drug
is detectable at a concentration of 300 μM and above when the
LiTaO3 detector is used in a 4 min measurement. However,
when the MCT detector is used in combination with the long
pass ﬁlter, 5-FU is detectable at 20 μM (Figure 2B). Calibration
curves extracted from these data are shown in Figure 2 (panels
C and D). When using the LiTaO3 detector, the peak-to-peak
noise of the absorbance spectra (Figure 2A) is ∼75 μa.u.
(estimated by measuring the absorbance diﬀerence between the
peak and trough in the 1300−1270 cm−1 region), while the
peak height of the 5-FU band at 300 μM is ∼230 μa.u.
(estimated by measuring the diﬀerence in absorbance between
the peak at 1254 cm−1 to the baseline of the peak, which is a
straight line from 1280 to 1200 cm−1) giving a SNR of 3, which
is considered as just detected. In contrast, when the MCT
detector is used in combination with the long pass ﬁlter, the
peak-to-peak noise, estimated in the same way as the data
measured with LiTaO3 detector (Figure 2B), is ∼2 μa.u. while
the peak height of the drug band at 20 μM is ∼15 μa.u., which
gives a SNR of 7.5. Furthermore, when measured with the
MCT detector combined with the long pass ﬁlter, the
calibration curve for 5-FU is linear down to 20 μM 5-FU.
Therefore, using the LiTaO3 detector limits the study of 5-FU
in the cell culture to, at best, 300 μM, while the MCT detector
with the long pass ﬁlter gives better SNR spectra and a more
than 15 times better limit of detection leading to a greater
accuracy at a low concentration level than is currently achieved
in the in vitro studies. Using the DTGS detector, the detection
limit is found to be 170 μM (Figure S-4 of the Supporting
Information), which is a slight improvement when compared to
the LiTaO3 detector but is still signiﬁcantly worse than the
MCT detector with a long pass ﬁlter approach.
In order to demonstrate that it is possible to study the 5-FU
in living cells, INS cells were used. The INS cells were used
because previously it has been shown that they are able to reach
near conﬂuency on a ZnS substrate when grown in L15 culture
medium, and the cell viability with this cell culturing condition
has been veriﬁed with the Trypan blue assay and visible
monitoring of the cell morphology (see Figure S-5 of the
Supporting Information). For the in situ multibounce ATR
FTIR measurements, the INS cells were seeded at relatively
Figure 3. (A) Diﬀerence FTIR spectra of the living cell measured using the MCT detector with the low-pass ﬁlter before and after the addition of 80
μM of drug in the medium. The “before” spectrum is the diﬀerence between two consecutive FTIR measurements of the cells with 4 min time
intervals before the addition of drug. The “4 min”, “8 min”, ... , ”20 min” spectra are the diﬀerence between the spectrum of the living cell measured
immediately after the addition of the drug and the spectrum measured at 4, 8, ..., 20 min after the addition of the drug. (B) Diﬀerence spectra of the
living cells after the addition of drug with the contribution from the growth of the living cells subtracted to highlight the changes in the living cell
composition as a result of the added drug. (C) A plot showing the concentration of 5-FU measured in the living cell as a function of time after the
addition of 80 μM of the drug in the medium using the MCT detector with the low-pass ﬁlter. (D) A repeat experiment of (C) measured with the
LiTaO3 detector and an increased concentration of 5-FU of 400 μM. Error bars representing the uncertainties from the spectral noise.
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high density and incubated to allow them to reach high
conﬂuency on the measuring surface of the ZnS ATR element
(Figure 1). Before the addition of drug, the spectra of the living
cells were monitored at a 4 min interval, and the viability and
conﬂuency of the cells was veriﬁed by monitoring the cell
morphology. The diﬀerence between two consecutive measure-
ments made at 4 min intervals shows a small increase in
absorbance of the living cells (Figure 3A, spectrum “before”),
indicating that there was a small increase in the amount of cells
on the ATR element, which was expected from a living cell
culture. The 5-FU solution was then added to the culture
medium such that the concentration of 5-FU was ∼80 μM. The
ﬁrst measurement acquired immediately after adding the drug
was used as the reference spectrum to subtract from all the
subsequent measurements, which were also acquired at 4 min
intervals. Hence, the diﬀerence spectrum labeled 4 min in
Figure 3A is the measurement started at 4 min after the
addition of drug subtracted by the ﬁrst measurement (the
reference) acquired immediately after the addition of drug, and
the diﬀerence spectrum labeled 8 min in Figure 3A is the
measurement started at 8 min subtracted by the ﬁrst
measurement (the reference) after the addition of drug.
Diﬀerence FTIR spectra of the cells, before and after the
addition of 5-FU, are shown in Figure 3A. Since the measured
signal is from the average of ∼3 million cells (the number of
cells being measured in a single measurement is estimated to be
3 million, see method for details), the cell-to-cell variations are
averaged and only the total growth of the cells and the eﬀect of
the added drug are observed. Most importantly, the 5-FU band
at 1254 cm−1 in the cells can be clearly seen and it was
increasing as a function of time, indicative that the drug was
diﬀusing into the living cells. A number of other bands that do
not belong to the drug have also increased as a function of time,
including the amide II band at 1540 cm−1, the amide III at
∼1240 cm−1, and the DNA bands at around 1080 cm−1. These
bands belong to the living cells as shown by the spectrum
before the addition of the drug. To reduce the contribution to
the spectral band, changes due to the growth of the living cells,
a second subtraction of the living cell spectrum has been
performed. The spectrum of the cells before the addition of the
drug (the “before” spectrum in Figure 3A), which represent the
spectrum of the cells without the drug, was subtracted from the
spectra, also in Figure 3A, of the live cells 4, 8, 12, 16, and 20
min after the addition of the drug, and the results are shown in
Figure 3B. Noting that 5-FU does not have strong absorbance
in the 1080 cm−1 region, the DNA band of the cell at 1080
cm−1 was used as the indicator of complete subtraction; the
subtraction is completed when the 1080 cm−1 band is
minimized. After the subtraction, the increase in the 5-FU
band at 1254 cm−1 is more pronounced and therefore more
easily quantiﬁed. There are also other subtle changes in the
spectrum of the living cells that have been detected, such as the
reduction of the bands at 1612, 1507, and 1410 cm−1. A blank
medium of 20 μL without drug was added to the live cells to
characterize any placebo eﬀect. The result has shown that the
addition of the blank medium did not produce the observed
changes when the drug was added. These spectral changes
could be a result of a change in the concentration of
metabolites in the cells induced by the drug. Nevertheless,
the presence of these bands does not alter the conclusions of
the present study. Even though their investigation is outside the
scope of this paper, it is important to highlight that the spectral
changes of the living cells as a result of the addition of drug are
small (in the range of 0.0001 au), despite the relatively long
path length of ∼30 μm used in these measurements, which
further underlined the importance of achieving low noise levels
in the study of living cells using FTIR spectroscopy. The
amount of 5-FU in the living cells has been quantiﬁed by
integrating the area under the band at 1254 cm−1 of the spectra
shown in Figure 3B and using the calibration curve shown in
Figure 2D, and the result is shown in Figure 3C. The
concentration of drug increases as a function of time and
reached equilibrium after ∼16 min at a drug concentration of
∼70 μM, which is slightly below the concentration of drug in
the medium. The experiment was repeated using the LiTaO3
detector, and it was found that the drug concentration applied
was required to be increased to 400 μM before the 5-FU can be
detected in the living cells (see Figure 3D). Nevertheless, using
the calibration curve in Figure 2C, the diﬀusion proﬁle is
obtained, which is remarkably similar to Figure 3C showing a
steady increase of the concentration of drug in the cells and
reaching a plateau at 16 min. Figure 3C also shows that the
concentration of drug in the cells increases linearly with time
and a ﬂux of drug of 0.4 nmol m−2 s−1 can be calculated from
the gradient. However, the experiment will beneﬁt from higher
temporal resolution, which can be achievable with slightly
lowered SNR.
The drug concentrations in cells were also measured using
the standard HPLC method (Figure 4), based on a method
previously described for the quantiﬁcation of 5-FU.24 The
HPLC method showed linearity in a concentration range
appropriate for the intracellular concentration of 5-FU, between
0.5 and 100 μM, and a calibration curve with R2 of 0.9997 was
built with the area of the 5-FU peak detected at 260 nm. The
intracellular drug concentration measured by HPLC reached an
equilibrium at the same time as in the FTIR experiments, after
approximately 16 min, but at a value of 50 instead of 70 μM.
This diﬀerence may be due to the method used in the
measurement of cell volume in the HPLC experiment, which
may include gaps between cells, extracellular matrix, and the
cellular membrane itself, leading to a slight overestimation of
the overall volume of the cells, hence a slight underestimation
of the concentration of drug. The FTIR data, on the other
hand, are directly collected from the cytoplasm, therefore
providing a more accurate measure of the intracellular
concentration. Comparing to a previous ex situ measurement
of radio-labeled 5-FU concentration in Lettre cells, the diﬀusion
of drug to the INS cells appears to be slower and does not show
the partitioning eﬀect.26 As pointed out in that work, however,
Figure 4. Ex situ quantiﬁcation of intracellular concentration of 5-FU
by HPLC 0, 4, 8, 16, and 24 min after addition of the drug. Error bars
represent standard deviation from triplicates.
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the ratio of internal and external cellular drug concentration is a
function of the pH gradient which was not determined in the
current study. Furthermore, a diﬀerent cell line was used in that
previous study which can lead to the diﬀerent response
observed. A direct comparison of the drug diﬀusion in diﬀerent
cell lines will be a future study.
■ CONCLUSION
Signiﬁcantly, this work has demonstrated that highly sensitive
measurement of drug concentration in living cells can be
achieved with equipment that is readily available in many
laboratories or, at most, requires the purchase of a small
multibounce ATR accessory. The cost of the ﬁlter and the
multibounce ATR accessory that is needed to perform this
experiment is minimal compared to other more sophisticated
label-free techniques that may be used for the measurement of
drug concentration in living cells such as stimulated Raman
scattering.27 The method developed here is both relatively
straightforward, with minimal interference by extrinsic factors
and nondestructive, allowing the living cells to undergo further
analysis if necessary. Measurement of drug concentration in
living cells has been demonstrated using INS cells, but other
cell lines such as HeLa and PC-3 have also been successfully
tested for other ongoing studies, whose results will be reported
in separate publications. The increase in drug concentration as
a function of time has been quantiﬁed using the multibounce
ATR FTIR system demonstrating that this method is suitable
to track the process of drug diﬀusion in living cells in a label-
free and nondestructive manner.
It is important to note that the SNR can be further improved
by using a nitrogen purge or else by fully upgrading the
spectrometer (e.g., to a vacuum system with gold coated
mirrors) to increase the throughput of light and eliminate the
atmospheric contribution to the noises in the background. New
developments in infrared spectroscopy such as the use of
quantum cascade laser as the infrared source28 may further
improve the sensitivity of this technique to allow the detection
of drug in nanomolar levels. Nevertheless, this work has
demonstrated that the sensitivity provided with the presented
technique is high enough to measure the 5-FU drug in living
cells at a clinical relevant concentration level, using standard
FTIR equipment.
In summary, the method has been demonstrated to be a
viable tool for detecting and quantifying drugs and other
relevant biomolecules in living cells without the need for
additional labeling. This method can be applied for studying
drug eﬃcacy, drug screening purposes in the development of
new drugs, or as a tool to understand the mechanism of drug
resistance.
■ ASSOCIATED CONTENT
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Optical path length for FTIR measurements of live cells; a
summary of the number of bounces required; a plot showing
the relationships between the relative SNR and path length at
diﬀerent spectral regions when the analyte is measured in
water; ratio of the intensity of two consecutive measurements
with deionized water on the ZnS ATR element; spectrum of
pure 5-FU solution in the 1800−1000 cm−1 region; diﬀerence
IR spectra of 5-FU in medium at various concentration levels
and calibration curve obtained from the measurement; and
visible image of live cells on ZnS substrate in L15 medium. This
material is available free of charge via the Internet at http://
pubs.acs.org.
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